CDM Trademark

Trademark Overview

On Thursday, December 7, 2017, a trademark application was filed for CDM with the United States Patent and Trademark Office. The USPTO has given the CDM trademark a serial number of 79228852. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 28, 2025. This trademark is owned by Indigo Diabetes N.V.. The CDM trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, sensors and instruments for the measurement of glucose, lactate and urea levels on patients
cdm

General Information

Serial Number79228852
Word MarkCDM
Filing DateThursday, December 7, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 28, 2025
Registration Number5537993
Registration DateTuesday, August 14, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Goods and ServicesMedical devices, namely, sensors and instruments for the measurement of glucose, lactate and urea levels on patients

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 28, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIndigo Diabetes N.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameIndigo Diabetes N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameIndigo Diabetes N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Monday, April 2, 2018NON-FINAL ACTION WRITTEN
Monday, April 9, 2018REFUSAL PROCESSED BY MPU
Thursday, March 22, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 23, 2018ASSIGNED TO EXAMINER
Tuesday, March 27, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, April 3, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 9, 2018NOTICE OF PUBLICATION
Wednesday, May 16, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 16, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Saturday, June 2, 2018NOTIFICATION PROCESSED BY IB
Monday, April 9, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 27, 2018REFUSAL PROCESSED BY IB
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, November 14, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 28, 2025CANCELLED SECTION 71
Friday, December 21, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 3, 2018FINAL DISPOSITION PROCESSED
Monday, December 3, 2018FINAL DISPOSITION NOTICE SENT TO IB

Related Keywords

lactate urea levels patients glucose measurement devices namely sensors instruments